Paul Tudor Jones Madrigal Pharmaceuticals, Inc. Transaction History
Tudor Investment Corp Et Al
- $25.1 Billion
- Q4 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 10,327 shares of MDGL stock, worth $3.47 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,327
Previous 1,400
637.64%
Holding current value
$3.47 Million
Previous $297,000
972.73%
% of portfolio
0.01%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding MDGL
# of Institutions
335Shares Held
22.3MCall Options Held
960KPut Options Held
940K-
Janus Henderson Group PLC London, X02.21MShares$743 Million0.36% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$687 Million38.14% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$682 Million9.12% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$670 Million10.03% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$664 Million6.75% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.75B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...